← naar grote beleggers
Deerfield Management Company, L.P
institutionele belegger · portefeuille $9.59 mld. · 82 posities · rapport per 30.06.2026
Aandelenposities rapport over 30.06.2026, ingediend op 14.08.2026; verandering — t.o.v. 31.03.2026 · 84
| Bedrijf | Aandelen | Waarde | % van de portefeuille | Verandering per Kwartaal |
|---|---|---|---|---|
| NUVALENT INC CUSIP 670703107 | 17 248 450 | $2.13 mld. | 26.52% | — |
| Revolution Medicines, Inc. US:RVMD | 2 392 000 | $448 mln. | 5.58% | +95 000 |
| Praxis Precision Medicines I… US:PRAX | 963 351 | $323 mln. | 4.02% | — |
| Viatris Inc US:VTRS | 20 206 170 | $321 mln. | 4.00% | — |
| Centene Corp US:CNC | 4 901 000 | $315 mln. | 3.92% | −1 016 091 |
| UNITED THERAPEUTICS Corp US:UTHR | 457 000 | $248 mln. | 3.08% | — |
| Legend Biotech Corp US:LEGN · certificaat van aandelen | 8 137 638 | $235 mln. | 2.93% | +450 000 |
| Cogent Biosciences Inc US:COGT | 5 006 104 | $194 mln. | 2.41% | −4 037 799 |
| Genmab A/S US:GMAB · certificaat van aandelen | 6 865 000 | $189 mln. | 2.35% | +4 403 000 |
| Brookdale Senior Living Inc US:BKD | 11 637 032 | $187 mln. | 2.33% | — |
| Vera Therapeutics Inc US:VERA | 3 916 400 | $168 mln. | 2.09% | +194 300 |
| Ionis Pharmaceuticals Inc US:IONS | 1 979 669 | $157 mln. | 1.95% | — |
| Celcuity LLC US:CELC | 1 451 014 | $152 mln. | 1.89% | −262 986 |
| BioCryst Pharmaceuticals Inc US:BCRX | 15 096 403 | $151 mln. | 1.88% | +58 403 |
| NEWAMSTERDAM PHARMA COMPANY CUSIP N62509109 | 4 264 789 | $145 mln. | 1.80% | — |
| Acadia Healthcare Company, I… US:ACHC | 4 520 000 | $133 mln. | 1.66% | — |
| Tango Therapeutics, Inc. US:TNGX | 4 190 611 | $131 mln. | 1.63% | +43 798 |
| Adapthealth Corp US:AHCO | 11 477 730 | $120 mln. | 1.49% | — |
| PHARVARIS N V CUSIP N69605108 | 3 376 042 | $117 mln. | 1.45% | +250 000 |
| Arrowhead Pharmaceuticals In… US:ARWR | 1 389 055 | $113 mln. | 1.41% | −184 242 |
| Dianthus Therapeutics Inc. US:DNTH | 1 125 313 | $110 mln. | 1.37% | +105 500 |
| Larimar Therapeutics Inc US:LRMR | 35 606 974 | $109 mln. | 1.35% | — |
| Mineralys Therapeutics, Inc. US:MLYS | 3 958 000 | $107 mln. | 1.33% | nieuw |
| Ideaya Biosciences Inc US:IDYA | 2 714 503 | $101 mln. | 1.26% | +1 184 495 |
| Xenon Pharmaceuticals Inc US:XENE | 1 615 696 | $97.5 mln. | 1.21% | — |
| Savara Inc US:SVRA | 13 569 000 | $83.6 mln. | 1.04% | — |
| Lantheus Holdings Inc US:LNTH | 752 999 | $83.5 mln. | 1.04% | −75 000 |
| Syndax Pharmaceuticals Inc US:SNDX | 3 779 900 | $82.6 mln. | 1.03% | — |
| Biomarin Pharmaceutical Inc US:BMRN | 1 332 836 | $76.3 mln. | 0.95% | +481 280 |
| Pfizer Inc US:PFE | 3 040 000 | $73.2 mln. | 0.91% | — |
| Indivior PLC US:INDV | 1 648 895 | $67.7 mln. | 0.84% | −1 448 895 |
| Bio-Rad Laboratories Inc US:BIO | 226 070 | $66.4 mln. | 0.83% | — |
| ARS Pharmaceuticals, Inc US:SPRY | 7 503 812 | $60.1 mln. | 0.75% | — |
| Stoke Therapeutics, Inc. US:STOK | 1 823 500 | $59.7 mln. | 0.74% | — |
| Structure Therapeutics Inc.… US:GPCR · certificaat van aandelen | 1 086 000 | $58.3 mln. | 0.73% | +318 007 |
| Envista Holdings Corp US:NVST | 2 210 100 | $58.2 mln. | 0.73% | — |
| Inspire Medical Systems Inc US:INSP | 1 296 862 | $57.9 mln. | 0.72% | −1 406 376 |
| CareDx Inc US:CDNA | 1 997 618 | $56.9 mln. | 0.71% | −193 382 |
| Boston Scientific Corp US:BSX | 1 315 000 | $56.1 mln. | 0.70% | nieuw |
| Belite Bio Inc ADR US:BLTE · certificaat van aandelen | 357 199 | $55.0 mln. | 0.68% | +53 186 |
| Parabilis Medicines, Inc. US:PBLS | 1 880 704 | $51.5 mln. | 0.64% | nieuw |
| Certara Inc US:CERT | 7 512 928 | $49.2 mln. | 0.61% | −295 677 |
| Disc Medicine Inc. US:IRON | 657 000 | $48.1 mln. | 0.60% | — |
| BridgeBio Oncology Therapeut… US:BBOT | 4 885 446 | $37.2 mln. | 0.46% | — |
| Tyra Biosciences Inc US:TYRA | 1 017 000 | $32.5 mln. | 0.40% | +468 000 |
| Monopar Therapeutics Inc US:MNPR | 323 745 | $30.0 mln. | 0.37% | — |
| Sionna Therapeutics, Inc. US:SION | 680 916 | $30.0 mln. | 0.37% | −289 674 |
| Avalyn Pharma Inc. US:AVLN | 731 000 | $24.1 mln. | 0.30% | nieuw |
| Foghorn Therapeutics Inc US:FHTX | 4 394 367 | $21.4 mln. | 0.27% | — |
| Beta Bionics, Inc. US:BBNX | 1 324 000 | $20.7 mln. | 0.26% | — |
| Alnylam Pharmaceuticals Inc US:ALNY | 67 935 | $20.5 mln. | 0.25% | — |
| Bright Minds Biosciences Inc US:DRUG | 283 000 | $19.9 mln. | 0.25% | — |
| Odyssey Therapeutics, Inc. US:ODTX | 1 046 139 | $19.6 mln. | 0.24% | nieuw |
| The Oncology Institute, Inc. US:STLN | 3 360 052 | $18.2 mln. | 0.23% | — |
| Kyverna Therapeutics, Inc. US:KYTX | 2 000 000 | $17.8 mln. | 0.22% | — |
| Alamar Biosciences, Inc. US:ALMR | 600 000 | $16.3 mln. | 0.20% | nieuw |
| Chemed Corp US:CHE | 30 000 | $14.0 mln. | 0.17% | nieuw |
| SpyGlass Pharma, Inc. US:SGP | 550 000 | $12.2 mln. | 0.15% | — |
| Adagene Inc. US:ADAG · certificaat van aandelen | 2 666 666 | $11.2 mln. | 0.14% | nieuw |
| Hemab Therapeutics Holdings,… US:COAG | 275 000 | $10.1 mln. | 0.13% | nieuw |
| Mobia Medical, Inc. US:MOBI | 670 752 | $8.99 mln. | 0.11% | nieuw |
| Embecta Corp US:EMBC | 2 534 961 | $8.26 mln. | 0.10% | — |
| Veracyte Inc US:VCYT | 101 000 | $5.93 mln. | 0.07% | −625 000 |
| Annexon, Inc. US:ANNX | 583 913 | $3.33 mln. | 0.04% | — |
| Alector Inc US:ALEC | 1 055 192 | $2.12 mln. | 0.03% | — |
| NEWAMSTERDAM PHARMA COMPANY CUSIP N62509117 | 92 787 | $1.98 mln. | 0.02% | — |
| Edwards Lifesciences Corp US:EW | 13 702 | $1.24 mln. | 0.02% | — |
| Mirum Pharmaceuticals Inc US:MIRM | 6 027 | $706 k | 0.01% | nieuw |
| Humana Inc US:HUM | 917 | $364 k | 0.00% | — |
| THE ONCOLOGY INSTITUTE INC CUSIP 68236X118 | 1 250 000 | $51.0 k | 0.00% | — |
| Pmv Pharmaceuticals Inc US:PMVP | 8 790 | $11.8 k | 0.00% | — |
| SURROZEN INC CUSIP 86889P117 | 166 666 | $2.75 k | 0.00% | — |
| DAY ONE BIOPHARMACEUTICALS I CUSIP 23954D109 | 0 (was 3 723 131) | — | — | verkocht |
| ENHABIT INC CUSIP 29332G102 | 0 (was 4 747 746) | — | — | verkocht |
| Kymera Therapeutics Inc US:KYMR | 0 (was 561 170) | — | — | verkocht |
| Myriad Genetics Inc US:MYGN | 0 (was 505) | — | — | verkocht |
| Neurocrine Biosciences Inc US:NBIX | 0 (was 610 000) | — | — | verkocht |
| QUANTUM SI INC CUSIP 74765K113 | 0 (was 333 333) | — | — | verkocht |
| Taysha Gene Therapies Inc US:TSHA | 0 (was 2 722 165) | — | — | verkocht |
| Veradermics, Incorporated US:MANE | 0 (was 5 000) | — | — | verkocht |
| BIOMX INC CUSIP 09090D509 | 0 (was 131 272) | — | — | verkocht |
| CATALYST PHARMACEUTICALS INC CUSIP 14888U101 | 0 (was 3 943 600) | — | — | verkocht |
| Compass Therapeutics, Inc. US:CMPX | 0 (was 3 606 000) | — | — | verkocht |
| Cullinan Therapeutics, Inc. US:CGEM | 0 (was 386 169) | — | — | verkocht |
In bedrijven uit onze database 2
| Bedrijf | Belang | Aandelen | Rapportdatum |
|---|---|---|---|
| NewAmsterdam Pharma Company… | 3.57% | 4 264 789 | 2026-06-30 |
| Genmab A/S | 1.1% | 6 865 000 | 2026-06-30 |
advertentie